| Kimberly Sacco, RN, CRNA | |
|
446 Green St, Boone, NC 28607-3411 | |
| (602) 619-0011 | |
| Not Available |
| Full Name | Kimberly Sacco |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 446 Green St, Boone, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790148005 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 248794 (North Carolina) | Primary |
| 163W00000X | Registered Nurse | 248794 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner - University Medical Center Phoenix | Phoenix, AZ | Hospital |
| Tucson Medical Center | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner - University Hospital Based Physicians Llc | 1052614294 | 244 |
| Ias Arizona Pllc | 7517312648 | 145 |
News Archive
Nevro Corp., a medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has received approval from the United States Food and Drug Administration for its Senza spinal cord stimulation (SCS) system.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
Traumatic brain injury is a risk factor for epilepsy, though the relationship is not understood. A new study in mice, published in Cerebral Cortex, identifies increased levels of a specific neurotransmitter as a contributing factor connecting traumatic brain injury (TBI) to post-traumatic epilepsy. The findings suggest that damage to brain cells called interneurons disrupts neurotransmitter levels and plays a role in the development of epilepsy after a traumatic brain injury.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
More than 80 percent of immigrants residing in the U.S. without authorization near the California-Mexico border have a lifetime history of traumatic events, according to a new study from a psychologist at Rice University. Nearly 50 percent of these immigrants suffer from clinically significant psychological distress.
› Verified 9 days ago
| Entity Name | Banner - University Hospital Based Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750751566 PECOS PAC ID: 1052614294 Enrollment ID: O20160122000508 |
News Archive
Nevro Corp., a medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has received approval from the United States Food and Drug Administration for its Senza spinal cord stimulation (SCS) system.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
Traumatic brain injury is a risk factor for epilepsy, though the relationship is not understood. A new study in mice, published in Cerebral Cortex, identifies increased levels of a specific neurotransmitter as a contributing factor connecting traumatic brain injury (TBI) to post-traumatic epilepsy. The findings suggest that damage to brain cells called interneurons disrupts neurotransmitter levels and plays a role in the development of epilepsy after a traumatic brain injury.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
More than 80 percent of immigrants residing in the U.S. without authorization near the California-Mexico border have a lifetime history of traumatic events, according to a new study from a psychologist at Rice University. Nearly 50 percent of these immigrants suffer from clinically significant psychological distress.
› Verified 9 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Nogales |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487251799 PECOS PAC ID: 9335554625 Enrollment ID: O20210218002429 |
News Archive
Nevro Corp., a medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has received approval from the United States Food and Drug Administration for its Senza spinal cord stimulation (SCS) system.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
Traumatic brain injury is a risk factor for epilepsy, though the relationship is not understood. A new study in mice, published in Cerebral Cortex, identifies increased levels of a specific neurotransmitter as a contributing factor connecting traumatic brain injury (TBI) to post-traumatic epilepsy. The findings suggest that damage to brain cells called interneurons disrupts neurotransmitter levels and plays a role in the development of epilepsy after a traumatic brain injury.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
More than 80 percent of immigrants residing in the U.S. without authorization near the California-Mexico border have a lifetime history of traumatic events, according to a new study from a psychologist at Rice University. Nearly 50 percent of these immigrants suffer from clinically significant psychological distress.
› Verified 9 days ago
| Entity Name | Ias Arizona Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689359747 PECOS PAC ID: 7517312648 Enrollment ID: O20231010003129 |
News Archive
Nevro Corp., a medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has received approval from the United States Food and Drug Administration for its Senza spinal cord stimulation (SCS) system.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
Traumatic brain injury is a risk factor for epilepsy, though the relationship is not understood. A new study in mice, published in Cerebral Cortex, identifies increased levels of a specific neurotransmitter as a contributing factor connecting traumatic brain injury (TBI) to post-traumatic epilepsy. The findings suggest that damage to brain cells called interneurons disrupts neurotransmitter levels and plays a role in the development of epilepsy after a traumatic brain injury.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
More than 80 percent of immigrants residing in the U.S. without authorization near the California-Mexico border have a lifetime history of traumatic events, according to a new study from a psychologist at Rice University. Nearly 50 percent of these immigrants suffer from clinically significant psychological distress.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Sacco, RN, CRNA 446 Green St, Boone, NC 28607-3411 Ph: () - | Kimberly Sacco, RN, CRNA 446 Green St, Boone, NC 28607-3411 Ph: (602) 619-0011 |
News Archive
Nevro Corp., a medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has received approval from the United States Food and Drug Administration for its Senza spinal cord stimulation (SCS) system.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
Traumatic brain injury is a risk factor for epilepsy, though the relationship is not understood. A new study in mice, published in Cerebral Cortex, identifies increased levels of a specific neurotransmitter as a contributing factor connecting traumatic brain injury (TBI) to post-traumatic epilepsy. The findings suggest that damage to brain cells called interneurons disrupts neurotransmitter levels and plays a role in the development of epilepsy after a traumatic brain injury.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
More than 80 percent of immigrants residing in the U.S. without authorization near the California-Mexico border have a lifetime history of traumatic events, according to a new study from a psychologist at Rice University. Nearly 50 percent of these immigrants suffer from clinically significant psychological distress.
› Verified 9 days ago
Mr. Richard L Woods, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 193 Valley Stran Dr, Boone, NC 28607 Phone: 828-264-6161 Fax: 828-264-6961 | |
Mr. Jeffrey Lawrence Milhaupt, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 336 Deerfield Rd, Boone, NC 28607 Phone: 828-262-4256 | |
Ms. Deborah Joyce Flaherty, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 376 Deerfield Forest Pkwy, Boone, NC 28607 Phone: 828-264-4173 | |
Mrs. Renee Anne Troy I, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 336 Deerfield Rd, Boone, NC 28607 Phone: 828-262-4100 | |
Lance Curtis Campbell, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 336 Deerfield Rd, Watauga Medical Center, Boone, NC 28607 Phone: 828-262-4256 | |
Mr. Robert Russell Johnson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 336 Deerfield Rd, Boone, NC 28607 Phone: 828-262-4241 | |
Mr. Steven Timothy Meyer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 336 Deerfield Rd, Boone, NC 28607 Phone: 828-262-4100 Fax: 828-262-4103 |